FDA OKs Vitatron's pacemaker software upgrade:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Vitatron's Ventricular Rate Stabilization (VRS) software upgrade for patients implanted with the company's Selection AFm pacemaker system. VRS can help stabilise the rate of the heart's ventricles during episodes of conducted atrial fibrillation (AF), which may reduce the symptoms of AF. It can be uploaded into the pacemaker - without the need for surgery - simply by placing a programming device on the chest over the patient's pacemaker, says Vitatron, a unit of Medtronic.